The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: A retrospective study

Bone and Joint Journal

Volumn 96 B, Issue 2, 2014, Pages 259-262

  Guo, K J ^a   Zhao, F C ^a   Guo, Y ^a   Li, F L ^a   Zhu, L ^a   Zheng, W ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISONE; SUCCINIC ACID;

ADULT; ARTICLE; BONE RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FEMUR HEAD NECROSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SEVERE ACUTE RESPIRATORY SYNDROME; SEX DIFFERENCE; STEROID THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

AGE; FEMORAL HEAD; GENDER; OSTEONECROSIS; SARS; STEROID;

ADULT; AGE FACTORS; CHINA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR HEAD NECROSIS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STEROIDS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84939648706     PISSN: None     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.96B2.31935     Document Type: Article

References (33)

1. Mankin HJ. Nontraumatic necrosis of the bone (osteonecrosis). N Engl J Med 1992;326:1473-1479.
2. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head ten years later. J Bone Joint Surg [Am] 2006;88-A;1117-1132.
3. Zhao FC, Li ZR, Guo KJ. Clinical analysis of osteonecrosis of the femoral head induced by steroid. Orthop Surg 2012;4:28-34.
4. Zhang HY, Blunt L, Jiang XQ, et al. Femoral stem wear in cemented total hip replacement. Proc Inst Mech Eng H 2008;222:583-592.
5. Zhang H, Blunt L, Jiang X, Brown L, Barrans S. The significance of the micropores at the stem-cement interface in total hip replacement. J Biomater Sci Polym Ed 2011;22:845-856.
6. Zhang H, Brown L, Blunt L, Jiang X, Barrans S. The contribution of the micropores in bone cement surface to generation of femoral stem wear in total hip replacement. Trib Int 2011;44:1476-1482.
7. Williams HD, Browne G, Gie GA, et al. The Exeter universal cemented femoral component at 8 to 12 years: a study of the first 325 hips. J Bone Joint Surg [Br] 2002;84-B:324-334.
8. Zhang HY, Blunt LA, Jiang XQ, Fleming LT, Barrans SM. The influence of bone cement type on production of fretting wear on the femoral stem surface. Clin Biomech (Bristol, Avon) 2012;27:666-672.
9. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-282.
10. Oinuma K, Harada Y, Nawata Y, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 2001;60:1145-1148.
11. Campbell S, Sun CL, Kurian S, et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009;115:4127-4135.
12. Nagasawa K, Tada Y, Koarada S, et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 2005;14:385-390.
13. McAvoy S, Baker KS, Mulrooney D, et al. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010;16:1231-1236.
14. No authors listed. World Health Organization: Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003;78:81-83.
15. Zhang NF, Li ZR, Wei HY, Liu ZH, Hernigou P. Steroid-induced osteonecrosis: the number of lesions is related to the dosage. J Bone Joint Surg [Br] 2008;90-B:1239-1243.
16. Miyanishi K, Yamamoto T, Isisa T, et al. Effects of different corticosteroids on the development of osteonecrosis in rabbits. Rheumatology (Oxford) 2005;44:332-336.
17. Zhao FC, Li ZR, Zhang NF, et al. Lesion size change in osteonecrosis of the femoral head: a long-term prospective study with MRI. Int Orthop 2010;34:799-804.
18. Gardeniers JWM. The ARCO perspective for reaching one uniform staging system of osteonecrosis. In: Scoutens A, Arlet J, Gardeniers JWM, Hughes SPF, eds. Bone circulation and vascularization in normal and pathologic conditions. New York: Plenum, 1993:375-380.
19. Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res 2010;468:2715-2724.
20. Stern PJ, Watts HG. Osteonecrosis after renal transplantation in children. J Bone Joint Surg [Am] 1979;61-A:851-856.
21. Gregg PJ, Barsoum MK, Soppitt D, et al. Avascular necrosis of bone in children receiving high-dose steroid treatment. Br Med J 1980;281:116.
22. Nakamura J, Saisu T, Yamashita K, et al. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study. Arthritis Rheum 2010;62:609-615.
23. Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cell. Bone 2012;50:325-330.
24. Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, et al. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 2003;48:732-736.
25. Wever KE, Menting TP, Rovers M, et al. Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS One 2012;7:32296.
26. te Winkel ML, Pieters R, Hop WC, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol 2011;29:4143-4150.
27. Ikemura S, Yamamoto T, Nishida K, Motomura G, Iwamoto Y. Gender difference in the development of steroid-induced osteonecrosis in rabbits. Rheumatology (Oxford) 2010;49:1128-1132.
28. Zhu B, Liu ZQ, Chen GL et al. The distribution and gender difference of CYP3A activity in Chinese subjects. Br J Clin Pharmacol 2003;55:264-269.
29. Tokuhara Y, Wakitani S, Oda Y, et al. Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose. J Orthop Sci 2009;14:794-800.
30. Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S. Oxidative stress and vascular permeability in steroidinduced osteonecrosis model. J Orthop Sci 2004;9:509-515.
31. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics: 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:85-151.
32. Elmantaser M, Stewart G, Young D, et al. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia. Arch Dis Child 2010;95:805-809.
33. Mattano LA Jr, Nachman JB, Devidas M, et al. Increased incidence of osteonecrosis (ON) with a dexamethasone (DEX) induction for high risk acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group (COG). Blood 2008;112.